Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Supplements Under Class I Recall
10/16/2024
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang Wan capsules from 123Herbals are under a Class I recall for being tainted with the undeclared dexamethasone and chlorpheniramine.
All lots of Vail-Bon Jie Yang...
10/16/2024
Pharmacy Learning Network
News
Defective Nasal Spray Recalled
10/10/2024
Glenmark Pharmaceuticals Inc. USA is recalling Ryaltris nasal spray because of a defective delivery system.
Glenmark Pharmaceuticals Inc. USA is recalling Ryaltris nasal spray because of a defective delivery system.
Glenmark Pharmaceuticals Inc....
10/10/2024
Pharmacy Learning Network
News
Statin Recalled for Containing Anticonvulsant
10/10/2024
Nivagen Pharmaceuticals Inc. is recalling atorvastatin calcium tablets after a 400-mg carbamazepine extended-release tablet was found in a bottle.
Nivagen Pharmaceuticals Inc. is recalling atorvastatin calcium tablets after a 400-mg carbamazepine extended-release tablet was found in a bottle.
Nivagen Pharmaceuticals Inc. is...
10/10/2024
Pharmacy Learning Network

Advertisement

News
Class I Recall for COVID-19 Treatment
10/10/2024
Vials of Veklury (remdesivir) for injection are under a Class I recall after a customer found a glass particle in a vial.
Vials of Veklury (remdesivir) for injection are under a Class I recall after a customer found a glass particle in a vial.
Vials of Veklury (remdesivir)...
10/10/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
OTC Dry Eye Ointments Recalled for Sterility Concerns
10/02/2024
AbbVie Inc. is recalling more than 3 million tubes of Refresh PM and Refresh Lacri-Lube lubricant eye ointment due to a lack of assurance of sterility.
AbbVie Inc. is recalling more than 3 million tubes of Refresh PM and Refresh Lacri-Lube lubricant eye ointment due to a lack of assurance of sterility.
AbbVie Inc. is recalling more...
10/02/2024
Pharmacy Learning Network

Advertisement

News
Immunosuppressant Recalled
10/02/2024
Ascend Laboratories is recalling 117 493 bottles of mycophenolic acid delayed-release tablets after samples failed to meet dissolution specifications.
Ascend Laboratories is recalling 117 493 bottles of mycophenolic acid delayed-release tablets after samples failed to meet dissolution specifications.
Ascend Laboratories is recalling...
10/02/2024
Pharmacy Learning Network
News
Subpotent Ointment Recalled
10/02/2024
More than 2 million tubes of mupirocin ointment distributed by Glenmark Pharmaceuticals are under recall for subpotency.
More than 2 million tubes of mupirocin ointment distributed by Glenmark Pharmaceuticals are under recall for subpotency.
More than 2 million tubes of...
10/02/2024
Pharmacy Learning Network
News
RSV, hMPV, and PIV Linked With Severe Respiratory Disease in Hospitalized Adults
09/23/2024
Respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and parainfluenza virus (PIV) are associated with severe respiratory disease requiring augmented oxygenation or ventilation in general hospitalized patients, according to a...
Respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and parainfluenza virus (PIV) are associated with severe respiratory disease requiring augmented oxygenation or ventilation in general hospitalized patients, according to a...
Respiratory syncytial virus...
09/23/2024
Pharmacy Learning Network

Advertisement

News
Recall for Prescription Toothpaste
09/19/2024
A label mix-up has prompted Elevate Oral Care to recall a lot of Just Right 5000 toothpaste.
A label mix-up has prompted Elevate Oral Care to recall a lot of Just Right 5000 toothpaste.
A label mix-up has prompted...
09/19/2024
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use